Line of Credit	12 Months Ended
Dec. 31, 2013
Line of Credit	(8) LINE OF CREDIT On December 19, 2012, the Company entered into a Loan and Security Agreement (the “Doral Agreement”) with Doral Healthcare Finance, a division of Doral Money, Inc. The Doral Agreement provides for an asset-backed revolving credit facility of up to $7,000, subject to reserves and reductions to the extent of changes in the Company’s asset borrowing base. Borrowings under the Doral Agreement bear interest at a variable rate equal to the greater of (i) the British Bankers’ Association LIBOR rate as published in The Wall Street Journal for dollar deposits in the amount of $1,000 with a maturity of one month or (ii) 3% per annum, plus, in each case, a margin of 6.75%. The Doral Agreement requires monthly interest payments in arrears on the first day of each month. The Doral Agreement will mature on December 19, 2014. The Company may terminate the Doral Agreement at any time prior to the maturity date upon thirty days’ prior written notice and upon payment in full of all outstanding obligations under the Doral Agreement. If the Company terminates the Doral Agreement, the Company must pay a specified early termination fee. As of December 31, 2013, $5,820 was outstanding under the Doral Agreement and $1,071 was available for borrowing. The Doral Agreement requires a lockbox arrangement whereby all receipts are swept daily to reduce borrowings outstanding. This arrangement causes the Doral Agreement to be classified as a current liability. As of December 31, 2013, the effective interest rate under the Doral Agreement was 8% (7% interest rate and 1% fees). The Doral Agreement contains certain customary restrictive and financial covenants for asset-backed credit facilities. As of December 31, 2013, the Company was not in compliance with two of the quarterly financial covenants under the Doral Agreement, however the Company has received a covenant violation waiver for one of the financial covenant defaults. As a result, all amounts due under the credit agreement are callable by the lender. We are currently in discussions with the lender and expect to receive an additional waiver; however, no assurance can be given.

(8) LINE OF CREDIT

On December 19, 2012, the Company entered into a Loan and Security Agreement (the “Doral Agreement”) with Doral Healthcare Finance, a division of Doral Money, Inc. The Doral Agreement provides for an asset-backed revolving credit facility of up to $7,000, subject to reserves and reductions to the extent of changes in the Company’s asset borrowing base. Borrowings under the Doral Agreement bear interest at a variable rate equal to the greater of (i) the British Bankers’ Association LIBOR rate as published in The Wall Street Journal for dollar deposits in the amount of $1,000 with a maturity of one month or (ii) 3% per annum, plus, in each case, a margin of 6.75%. The Doral Agreement requires monthly interest payments in arrears on the first day of each month. The Doral Agreement will mature on December 19, 2014. The Company may terminate the Doral Agreement at any time prior to the maturity date upon thirty days’ prior written notice and upon payment in full of all outstanding obligations under the Doral Agreement. If the Company terminates the Doral Agreement, the Company must pay a specified early termination fee. As of December 31, 2013, $5,820 was outstanding under the Doral Agreement and $1,071 was available for borrowing.

The Doral Agreement requires a lockbox arrangement whereby all receipts are swept daily to reduce borrowings outstanding. This arrangement causes the Doral Agreement to be classified as a current liability.

As of December 31, 2013, the effective interest rate under the Doral Agreement was 8% (7% interest rate and 1% fees).

The Doral Agreement contains certain customary restrictive and financial covenants for asset-backed credit facilities. As of December 31, 2013, the Company was not in compliance with two of the quarterly financial covenants under the Doral Agreement, however the Company has received a covenant violation waiver for one of the financial covenant defaults. As a result, all amounts due under the credit agreement are callable by the lender. We are currently in discussions with the lender and expect to receive an additional waiver; however, no assurance can be given.